Clinical Trials in Stavanger, Rogaland
10 recruiting
Showing 1–10 of 10 trials
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC1,530 enrolled288 locationsNCT06393374
Recruiting
Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC868 enrolled229 locationsNCT06077760
Recruiting
Phase 3
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast NeoplasmsTriple Negative Breast NeoplasmsHR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC2,400 enrolled268 locationsNCT06966700
Recruiting
Phase 3
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Multiple Myeloma
Pfizer944 enrolled238 locationsNCT05020236
Recruiting
Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
AbbVie1,280 enrolled279 locationsNCT06468228
Recruiting
Not Applicable
ASD and Habituation to Dental Examination
Autism Spectrum DisorderOral Health TrainingHabituation
Oral Health Center of Expertise Rogaland, Norway225 enrolled2 locationsNCT06933342
Recruiting
Phase 3
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
Prostate Cancer
Sven Löffeler980 enrolled18 locationsNCT05448547
Recruiting
Not Applicable
The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL)
ProgressionExperience, LifeLabor (Obstetrics)--Complications+5 more
Ostfold Hospital Trust23,650 enrolled10 locationsNCT05791630
Recruiting
Not Applicable
Small Macular Holes Treated With Air
Macular Holes
Helse Stavanger HF132 enrolled7 locationsNCT06211907
Recruiting
Phase 2
Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)
Alzheimer DiseaseCognitive Decline, Mild
Helse Stavanger HF200 enrolled6 locationsNCT06362707